Navigation Links
ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
Date:12/6/2011

subcutaneous dispersion and absorption of these drugs. Molecules as large as 200 nanometers may pass freely through the extracellular matrix, which recovers its normal density within approximately 24 hours, leading to a drug delivery platform which does not permanently alter the architecture of the skin. The principal focus of Halozyme's Enhanze technology platform is the use of rHuPH20 to facilitate subcutaneous administration for large molecule biological therapeutics, some of which currently require intravenous administration.

About Hereditary Angioedema (HAE)

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States and at least 10,000 people in the European Union.

For more information on HAE, visit the HAEi's (International Patient Organization for C1 Inhibitor Deficiencies) website at www.haei.org and the U.S. HAE Association's website at: www.haea.org.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet med
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ViroPharma to Participate in Two November Healthcare Investor Conferences
2. ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline
3. ViroPharma Incorporated Reports Third Quarter 2011 Financial Results
4. ViroPharma to Release 2011 Third Quarter Financial Results on October 27, 2011
5. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
6. ViroPharma Announces Additional Securities Repurchase Program
7. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
8. ViroPharmas Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
9. ViroPharma to Participate in the Stifel Nicolaus 2011 Healthcare Conference
10. ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
11. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... collagenase-based products marketed as XIAFLEX ® in the U.S. ... BioSpecifics, President, Tom Wegman , will present a corporate ... the Biotech Industry Conference. The presentation will ... EDT at the Millennium Broadway Hotel in New ...
(Date:9/19/2014)... -- Over 200 runners participated in the fifth annual 5K ... Institute (ROI), hosted by Radiation Business Solutions. This year the ... Francisco.  "Donations are still coming in," ... Solutions, "but at this point, through registrations and ... ROI this year. This surpasses last year,s record of ...
(Date:9/19/2014)... CAMBRIDGE, Mass. , Sept. 19, 2014 ... a provider of advanced cancer genome analysis and ... leader in discovering and developing highly selective kinase ... first-ever comprehensive genomic study of malignant mixed Mullerian ... the female reproductive system, also known as carcinosarcoma. ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... PARIS , June 3, 2010 ... together global,forces in personalised medicine, has today announced the ... personalised healthcare, as Executive,Director and board member. Dr. Bruinvels ... with the board of directors, for building,its strategic framework ...
... RESEARCH TRIANGLE PARK, N.C. , June 2 ... announced that it has received a letter from the ... labeling for its respiratory products Serevent® and Advair®.  The ... FDA advisory committee meetings regarding the safety profile of ...
Cached Medicine Technology:EPEMED, the European Personalised Medicine Association, Appoints Executive Director 2EPEMED, the European Personalised Medicine Association, Appoints Executive Director 3GSK Announces Revised Product Labels for Serevent® and Advair® 2
(Date:9/20/2014)... 2014 The print component of ... of the Calgary Herald, with a circulation of ... 270,000. The digital component is distributed nationally through ... network of top news sites and partner outlets. ... visit http://www.worklifebalanceinfo.ca . , The publication features ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The festival season ... busy selling its newly released luxurious cocktail dresses . ... company has recently decided to launch a new promotion for ... is offered with a discounted price, from 20 to 71 ... a wide range of choices. They are provided in many ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 iFitDress.com, the ... gowns for women, has recently unveiled its new collection ... big sale for special offer on these new outfits; ... shopping season. All customers can now buy cheap ... The company’s sales representative says, “We have extensive experience ...
(Date:9/20/2014)... September 20, 2014 "As a nurse, patients ... tanks," said an inventor from Tamaqua, Pa. "The reason that ... the backs of their chairs. My invention enables them to ... Kam Oxygen Sensor to make it easier to monitor the ... user knows when the tank is low. It allows changeovers ...
(Date:9/20/2014)... September 20, 2014 QueenBeeTickets.com is ready ... star’s tour performances. She will visit many cities in ... until the 16th of April. , Click Here ... Tour tickets at QueenBeeTickets.com. , The star’s fans are ... see their favorite young singer in a live performance. ...
Breaking Medicine News(10 mins):Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2
... of an initiative to give back to the cancer ... meetings, the American Society for Radiation Oncology (ASTRO) is ... of cancer survivorship issues., Gilda,s Club South Florida will ... exhibit at ASTRO,s 53rd Annual Meeting, scheduled for October ...
... (Sept. 1, 2011) Patients often take drugs to ... develop ulcers from taking their anti-inflammatory drugs for conditions ... major problems for their small intestines, McMaster researchers have ... Digestive Health Research Institute has found those stomach acid-reducing ...
... THURSDAY, Sept. 1 (HealthDay News) -- Strokes are on ... report shows. The number of people aged 15 to ... 1995 and 2008, say researchers from the U.S. Centers for ... to the increasing numbers of young people who have diseases ...
... with ALK-rearranged non-small cell lung cancer (NSCLC) responded ... patients whose cancer did not show ALK translocation, ... of the Journal of Thoracic Oncology, the official ... of Lung Cancer (IASLC). Lung adenocarcinoma can ...
... researchers have successfully injected cultured red blood cells (cRBCs) created ... according to study results published today in ... Society of Hematology (ASH). As the global need for ... is decreasing, these study results provide hope that one day ...
... Sept. 1 (HealthDay News) -- Researchers report that they used ... successfully injected the blood cells back into the human donor ... The findings raise the possibility of creating individualized blood supplies ... they need a transfusion, a potentially dicey situation if someone ...
Cached Medicine News:Health News:Strokes Rising Among Teens, Young Adults: CDC 2Health News:Strokes Rising Among Teens, Young Adults: CDC 3Health News:Lung cancer ALK rearrangement may predict pemetrexed efficacy, study shows 2Health News:Researchers successfully perform first injection of cultured red blood cells in human donor 2Health News:Scientists Use Stem Cells for Blood 'Self-Transfusion' 2
... is an ultra-high speed, high resolution optical ... retina imaging and analysis. It ... Optical Coherence technology just emerging from clinical ... The ultra-high speed and high resolution ...
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... customer support. Delivering optimum performance with ... clear choice for medical professionals worldwide. ...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... performance with maximum comfort, SheerVision loupes ... professionals worldwide. All SheerVision loupes come ...
... SheerVision manufactures its signature line of award-winning ... Frame. These next generation loupes feature ... design, and are multi-coated lens for anti-glare, ... SV Sport frame offers a stylish, yet ...
Medicine Products: